Spain Vascular Access Device Market (2026-2031)
The Spain Vascular Access Device Market was valued at $57 Million in 2026 and projected to reach to $73.3 Million by 2031, representing a compound annual growth rate of 5.2%. Spain's vascular access device market is positioned for steady growth through 2031, driven by demographic pressures and evolving clinical needs.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Spain Vascular Access Device Market Trends and Insights
- This steady expansion in Spain reflects increasing demand for advanced vascular access solutions driven by an aging population and rising prevalence of chronic diseases requiring long-term intravenous therapy.
- Spain's healthcare infrastructure continues to modernize, with hospitals and clinics investing in improved vascular access technologies to enhance patient outcomes and reduce complications. The Spanish market benefits from strong regulatory frameworks and reimbursement policies that support the adoption of innovative vascular access devices.
- Spain's position within the European healthcare ecosystem enables access to cutting-edge technologies and best practices.
- Over the forecast period through 2031, Spain is expected to see sustained growth as healthcare providers prioritize patient safety and clinical efficiency in vascular access management..
Key Market Statistics
- CAGR (2026-2031) 5.2% CAGR
- Market Size, 2026 ~USD 57 Million
- Forecast, 2031 ~USD 73.3 Million
- Country Spain
Spain Vascular Access Device Market Overview
Market Size & Growth :
Spain's vascular access device market is valued at $57.0 million in 2026 and is projected to reach $73.3 million by 2031, with a CAGR of 5.2%, outpacing many European peers in adoption rates.
Aging Population Driver :
Spain's demographic shift toward an older population significantly increases demand for vascular access devices, as elderly patients require more frequent and prolonged intravenous therapies for chronic disease management.
Chronic Disease Prevalence :
Rising incidence of diabetes, cancer, and cardiovascular diseases in Spain necessitates expanded vascular access infrastructure, driving healthcare providers to invest in advanced device solutions for improved patient outcomes.
Healthcare System Modernization :
Spain's healthcare sector is increasingly adopting innovative vascular access technologies, supported by government healthcare initiatives and private sector investments in medical device infrastructure.
Spain Vascular Access Device Market Dynamics
- The aging population combined with rising chronic disease prevalence creates sustained demand for peripheral and central venous access solutions.
- Healthcare providers across Spain's public and private sectors are prioritizing advanced vascular access technologies to improve patient safety and reduce complications associated with traditional catheterization methods. The market outlook remains positive as Spanish hospitals and outpatient facilities modernize their vascular access capabilities.
- Increased awareness of infection prevention and improved clinical outcomes associated with newer device technologies will support market expansion.
- Additionally, growing investment in healthcare infrastructure and alignment with European medical device standards will facilitate market penetration of innovative solutions throughout Spain's healthcare system..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Spain's vascular access device market is valued at $57.0 million in 2026 and will reach $73.3 million by 2031.
- Spain experiences a 5.2% CAGR, reflecting steady demand for advanced vascular access solutions.
- Spain's aging population and rising chronic disease prevalence drive market expansion through 2031.
- Spain's robust healthcare infrastructure and reimbursement policies support continued adoption of innovative devices.
Vascular Access Device Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SUBCUTANEOUS (Route Of Insertion) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.7% from 2026 to 2031 |
| Largest Segment | INTRAVENOUS (Route Of Insertion) |
| Market Size Base Year (Billions) | ~USD 6.29 (2026) |
| Revenue Forecast (Billions) | ~USD 8.7 (2031) |
| Segments Covered | Type, Route Of Insertion, Application, End User |
Spain Vascular Access Device Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Accessories
- Butterfly/Winged Steel Needles
- Central Venous Access Devices
- Chemotherapy
- Implantable Conventional Ports
- Implantable Ports
- Implantable Power Injectable Ports
- Integrated/Accelerated Midline Catheters
- Intraosseous Vascular Access Devices
- Midline Catheters
- Mst Max Barrier Midline Catheters
- Non-Tunneled Catheters
- Other Drug Administration Applications
- Peripheral Arterial Access Devices
- Peripheral Intravenous Catheters
- Peripheral Vascular Access Devices
- Peripheral Venous Access Devices
- Peripherally Inserted Central Catheters
- Private
- Public
- Tunneled Catheters
By Route Of Insertion
- Intraosseous
- Intravenous
- Subcutaneous
By Application
- Blood Transfusion
- Diagnostics & Testing
- Drug Administration
- Fluid & Nutrition Administration
By End User
- Ambulatory Care Centers
- Clinics
- Hospitals
- Other End Users
SPAIN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY CARE CENTERS | 20.6 | 21.9 | 23.1 | 24.4 | 25.9 | 27.5 | 29.3 | 31.3 | 6.3 |
| CLINICS | 14.1 | 14.9 | 15.6 | 16.4 | 17.4 | 18.4 | 19.5 | 20.7 | 5.8 |
| HOSPITALS | 49 | 51.7 | 54 | 56.4 | 59.3 | 62.5 | 65.9 | 69.7 | 5.2 |
| OTHER END USERS | 10.3 | 10.9 | 11.5 | 12 | 12.7 | 13.4 | 14.2 | 15.1 | 5.7 |
| TOTAL | 93.9 | 99.4 | 104.2 | 109.3 | 115.2 | 121.8 | 129 | 136.9 | 5.6 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Spain-specific market data to develop localized product strategies, identify distribution partnerships, and allocate R&D resources for the Spanish vascular access device market.
- Healthcare Providers & Hospital Networks : Spanish hospitals and healthcare systems require market intelligence to benchmark procurement decisions, evaluate emerging technologies, and optimize vascular access protocols for patient safety and cost efficiency.
- Investment & Private Equity Firms : Investors targeting Spain's healthcare sector need detailed market forecasts and growth drivers to evaluate acquisition opportunities, assess portfolio company performance, and identify emerging market entrants.
- Healthcare Consultants & Advisors : Consulting firms advising Spanish healthcare organizations require granular market data to support strategic planning, competitive analysis, and technology adoption recommendations for vascular access solutions.
- Regulatory & Policy Bodies : Spanish health authorities and policy makers need market insights to inform healthcare infrastructure planning, reimbursement policies, and medical device regulations aligned with market dynamics and patient needs.
Key Companies in the Spain Vascular Access Device Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PENUMBRA, INC. | United States | Public Company | Neurovascular thrombectomy (Penumbra System, RED, JET, ACE, ENGINE, 3D Revascularization Device),Peripheral thrombectomy (Indigo, Lightning Flash, Lightning Bolt 7, CAT RX),Neuro and peripheral embolization (Ruby platforms, POD, coils, LANTERN, Packing Coil), |
| SANOFI | France | Public Company | Pediatric and Combination Vaccines (including hexavalent),Other Vaccines (RSV, travel, rabies, yellow fever, typhoid, hepatitis A),Immunology & Inflammation Therapies, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, IV and vascular access, sharps, basic disposables),Connected Care (infusion, medication management, pharmacy automation, informatics, hemodynamic monitoring),BioPharma Systems (prefillable drug delivery systems and related services), |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular access and emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),Interventional cardiology and peripheral (GuideLiner, Turnpike, TrapLiner, MANTA, DCBs, stents, balloons), |
| ICU MEDICAL INC. | United States | Public Company | IV solutions and diluents,Infusion pumps and hardware,Vascular access and needlefree connectors, |
| MERIT MEDICAL SYSTEMS | United States | Public Company | Cardiovascular – Peripheral Intervention (angiography, drainage, delivery, embolotherapy),Cardiovascular – Cardiac Intervention (access, EP/CRM, fluid management, hemodynamic, hemostasis),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy), |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion (syringes, catheters, IV sets),Glass pharma packaging and components, |
| ANGIODYNAMICS | United States | Public Company | Med Tech (Auryon, AlphaVac, AngioVac, NanoKnife, Solero, VenaCure EVLT),Med Device (peripheral catheters, guidewires, ports, drainage, micropuncture kits), |
| AMECATH | Egypt | Private Company | Dialysis catheters,Central venous and midline catheters,Urology catheters, |
PENUMBRA, INC.
PENUMBRA, INC. is a United States-based public company founded in 2004 with 4700 employees.
SANOFI
SANOFI is a French public company founded in 1994 with 74846 employees.
BECTON, DICKINSON AND COMPANY
BECTON, DICKINSON AND COMPANY is a United States-based public company founded in 1897 with 72000 employees.
TERUMO CORPORATION
TERUMO CORPORATION is a Japanese public company founded in 1921 with 30591 employees.
TELEFLEX INCORPORATED
TELEFLEX INCORPORATED is a United States-based public company founded in 1943 with 15500 employees.
ICU MEDICAL INC.
ICU MEDICAL INC. is a United States-based public company founded in 1984 with 13000 employees.
MERIT MEDICAL SYSTEMS
MERIT MEDICAL SYSTEMS is a United States-based public company founded in 1987 with 7500 employees.
NIPRO CORPORATION
NIPRO CORPORATION is a Japanese public company founded in 1954.
ANGIODYNAMICS
ANGIODYNAMICS is a United States-based public company founded in 1988 with 632 employees.
AMECATH
AMECATH is an Egypt-based private company founded in 1991.
Reasons to Buy this Report
- Spain-Specific Market Sizing : Obtain precise market valuation data for Spain ($57.0M in 2026, $73.3M in 2031) with country-level CAGR of 5.2%, enabling accurate financial forecasting and investment planning specific to the Spanish market.
- Demographic & Clinical Insights : Understand Spain's unique aging population dynamics and chronic disease burden driving vascular access device demand, allowing stakeholders to tailor product development and market entry strategies accordingly.
- Competitive Landscape Intelligence : Gain detailed analysis of Spain's vascular access device competitive environment, including key players, market share distribution, and regional healthcare provider preferences to inform strategic positioning.
- Healthcare System Navigation : Access insights into Spain's public and private healthcare infrastructure, reimbursement pathways, and regulatory requirements essential for successful market entry and commercial operations.
- Growth Opportunity Identification : Identify high-potential segments and geographic regions within Spain experiencing accelerated adoption of advanced vascular access technologies, enabling targeted resource allocation and revenue optimization.
Frequently asked questions
What is the current size of Spain's vascular access device market?
Spain's vascular access device market is estimated at $57.0 million in 2026.
What is the projected market size for Spain by 2031?
Spain's vascular access device market is projected to reach $73.3 million by 2031.
What is the CAGR for Spain's vascular access device market?
Spain's vascular access device market is expected to grow at a compound annual growth rate of 5.2% from 2026 to 2031.
What factors are driving growth in Spain's vascular access device market?
Spain's market growth is driven by an aging population, rising prevalence of chronic diseases, modernization of healthcare infrastructure, and strong reimbursement policies supporting device adoption.
How does Spain's market compare to other European markets?
Spain benefits from a robust healthcare system and regulatory framework that supports innovation, positioning it competitively within the European vascular access device market landscape.
RESEARCH METHODOLOGY
Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global vascular access device (VAD) market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the VAD market.
Secondary Research
In the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations of device manufacturers; regulatory filings and clearance databases; clinical literature and peer-reviewed journals; healthcare and infection-control association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. All of this information was further validated by primary sources.
Primary Research
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report: marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the vascular access device market. Primary sources on the demand side include directors and presidents of hospitals & cardiac centers, as well as scientists/researchers from academic & research institutes. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends and dynamics.
In the market engineering process, top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was conducted throughout the market engineering process to present key information and insights throughout the report.
After the complete market engineering process—including calculations for market statistics, market breakups, market size estimates, market forecasts, and data triangulation—extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also used to identify segmentation types, industry trends, the competitive landscape among VAD market players, and key market dynamics, including drivers, restraints, opportunities, challenges, and key strategies.
Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down and bottom-up approaches were used to estimate and validate the size of the VAD market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size included identifying key market players through secondary research and determining their market shares in each region through both primary and secondary research. This entire procedure included the study of the annual and financial reports of the top market players, and extensive interviews were conducted with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.
All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.
Data Triangulation
After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, where applicable, to complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
A vascular access device (VAD) is a medical device used to gain access to a patient's bloodstream for the administration of drugs, fluids, blood products, and nutrition, as well as for blood sampling and diagnostic procedures. VADs include peripheral devices (such as peripheral intravenous catheters, midline catheters, and arterial catheters), central devices (such as peripherally inserted central catheters, centrally and non-tunneled/tunneled central venous catheters, and implantable ports), and intraosseous access systems, along with related accessories. These devices incorporate features such as safety-engineered designs, antimicrobial and antithrombogenic coatings, and compatibility with ultrasound-guided insertion to ensure safe, reliable, and repeatable vascular access across hospital, ambulatory, and home-care settings.
Key Stakeholders
- Vascular access device manufacturers and suppliers
- Hospitals, clinics, and ambulatory care centers
- Clinicians (interventional radiologists, vascular access nurses, anesthesiologists, and intensivists)
- Hospital procurement teams and group purchasing organizations (GPOs)
- Infection-prevention and patient-safety professionals
- Distributors, dealers, and contract manufacturers
- Regulatory authorities and healthcare standards organizations
- Research institutes and academic medical centers
- Investors and technology partners
Report Objectives
- To describe and forecast the global vascular access device market by type, route of insertion, application, end user, and region from 2026 to 2031, and to analyze the various macroeconomic and microeconomic factors that affect market growth.
- To forecast the market size of five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
- To analyze the subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market.
- To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing market growth.
- To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape of major players.
- To profile key market players and comprehensively analyze their business overviews, regional presence, product offerings, business strategies, and key financials, and to illustrate the competitive landscape of the market.
- To analyze competitive developments such as mergers & acquisitions, product launches, partnerships and collaborations, and research & development (R&D) activities in the market.
Available customizations:
With the provided market data, MarketsandMarkets offers customizations tailored to company-specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakup of the Rest of Asia Pacific market, by country
- Further breakup of the Rest of Europe market, by country
- Further breakup of the Rest of Latin America market, by country
- Further breakup of the Middle East & African market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Get the Full Vascular Access Device Market Report
Full forecast, segment splits, and company analysis for all Vascular Access Device Market.
- US Vascular Access Device Market
- Canada Vascular Access Device Market
- Germany Vascular Access Device Market
- UK Vascular Access Device Market
- France Vascular Access Device Market
- Italy Vascular Access Device Market
- China Vascular Access Device Market
- India Vascular Access Device Market
- Japan Vascular Access Device Market
- Australia Vascular Access Device Market
- South Korea Vascular Access Device Market
- Brazil Vascular Access Device Market
- Mexico Vascular Access Device Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report